Profilo
Rami Skaliter is currently the Chief Executive Officer at Cell Cure Neurosciences Ltd., an External Director at Tikcro Technologies Ltd., and was previously the Chief Operating Officer at Quark Pharmaceuticals, Inc. He received an undergraduate degree from Ben-Gurion University of the Negev and graduate and doctorate degrees from Weizmann Institute of Science.
Posizioni attive di Rami Skaliter
| Società | Posizione | Inizio |
|---|---|---|
| TIKCRO TECHNOLOGIES LTD. | Direttore/Membro del Consiglio | 01/01/2016 |
Cell Cure Neurosciences Ltd.
Cell Cure Neurosciences Ltd. BiotechnologyHealth Technology Develops cell therapies for neural degenerative diseases | Amministratore Delegato | 01/06/2017 |
Precedenti posizioni note di Rami Skaliter
| Società | Posizione | Fine |
|---|---|---|
Quark Pharmaceuticals, Inc.
Quark Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers and develops novel RNAi-based therapeutics | Direttore operativo | - |
Formazione di Rami Skaliter
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Tikcro Technologies Ltd.
Tikcro Technologies Ltd. BiotechnologyHealth Technology Develops and distributes biotechnology technologies | Health Technology |
Quark Pharmaceuticals, Inc.
Quark Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers and develops novel RNAi-based therapeutics | Health Technology |
Ben-Gurion University of the Negev
Ben-Gurion University of the Negev Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Weizmann Institute of Science
Weizmann Institute of Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cell Cure Neurosciences Ltd.
Cell Cure Neurosciences Ltd. BiotechnologyHealth Technology Develops cell therapies for neural degenerative diseases | Health Technology |
















